A detailed history of Lvm Capital Management LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Lvm Capital Management LTD holds 14,290 shares of MRNA stock, worth $353,820. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,290
Holding current value
$353,820
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 12, 2026

BUY
$23.56 - $28.49 $336,672 - $407,122
14,290 New
14,290 $353,000
Q1 2023

Apr 17, 2023

BUY
$135.66 - $197.02 $670,838 - $974,263
4,945 New
4,945 $759,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Lvm Capital Management LTD Portfolio

Follow Lvm Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvm Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lvm Capital Management LTD with notifications on news.